Haemophilia
Издатель: Wiley · ISSN 13518216 · 58 статей
-
Validity and Reliability of a Thai Version of the Paediatric Haemophilia Activities List
ABSTRACT Introduction The Paediatric Haemophilia Activities List (PedHAL) is a self‐administered instrument for assessing activity limitations in children with haemophilia, yet no Thai version has previously undergone psychometric...
-
Clinical Determinants of von Willebrand Factor Antigen, Activity, and Factor VIII Levels in Transfusion‐Dependent Beta‐Thalassemia
ABSTRACT Introduction Von Willebrand factor (VWF) and factor VIII (FVIII) levels are influenced by multiple physiological and disease‐related factors. Patients with transfusion‐dependent beta thalassemia (TDT) present a complex clinical...
-
Impact of the Lebanese Crisis on the Treatment of Patients With Haemophilia and von Willebrand Disease
ABSTRACT Introduction Haemophilia and von Willebrand disease (VWD) are inherited bleeding disorders requiring lifelong access to haemostatic therapies and coordinated multidisciplinary care. Lebanon's prolonged economic and healthcare...
-
Development of Haemophilia Specialist Nurses and Current Status Survey of Nursing Practice in China
ABSTRACT Introduction Little is known about the breadth of nursing practice and its determinants among haemophilia specialist nurses in China. Aim To review the evolution of haemophilia specialist nursing in China and investigate the...
-
Why “Treat First” Stalls: Knowledge, Scope, and System Determinants of Delayed Haemostatic Therapy in the Emergency Department
Haemophilia, Volume 32, Issue 6, Page 1365-1377, November/December 2026.
-
Extended Half‐Life Recombinant Factor VIII Conjugated With Modifying Substances Does Not Affect Fibrin Clot Formation or Stability in Haemophilia A Blood Samples
Haemophilia, Volume 32, Issue 6, Page 1522-1531, November/December 2026.
-
The Analysis of the FIX‐inhibitor Risks Associated With the F9 Genotype in Patients With Haemophilia B Exposes the Involvement of Nonsense Mediated‐Decay: Argentinean and International Series
Haemophilia, Volume 32, Issue 6, Page 1488-1497, November/December 2026.
-
Haemophilia Management in Natural Disasters—From Field to Consensus Report
Haemophilia, Volume 32, Issue 6, Page 1359-1364, November/December 2026.
-
Real‐World Assessment of rVIII‐SingleChain for Prophylactic Treatment in People With Severe Hemophilia A in High‐Resource Settings
Haemophilia, Volume 32, Issue 6, Page 1421-1428, November/December 2026.
-
Physical Activity and Sedentary Behaviour in Children With Haemophilia
Haemophilia, Volume 32, Issue 6, Page 1505-1512, November/December 2026.
-
Beyond Body Weight: Biological and Clinical Determinants of Factor VIII Pharmacokinetics in Tunisian Patients
Haemophilia, Volume 32, Issue 6, Page 1413-1420, November/December 2026.
-
Catastrophic Health Expenditure and Health‐Related Quality of Life Impairment in Severe Haemophilia A: A Patient‐Level Cost‐of‐Illness Study From India
Haemophilia, Volume 32, Issue 6, Page 1444-1454, November/December 2026.
-
Smartphone‐Based Teledentistry to Support Clinical Triage and Risk‐Informed Dental Care in Patients With Inherited Bleeding and Haemoglobin Disorders: A Cross‐Sectional Diagnostic Agreement Study
Haemophilia, Volume 32, Issue 6, Page 1378-1386, November/December 2026.
-
Real‐World Outcomes of Prophylaxis With rIX‐FP in Germany: A Prospective, Non‐Interventional Study in Haemophilia B
Haemophilia, Volume 32, Issue 6, Page 1429-1443, November/December 2026.
-
Prophylactic Factor Replacement Versus on‐Demand Factor Replacement Following Primary Total Knee Arthroplasty in Patients With Hemophilia: A Retrospective Study With an Average 10‐Year Follow‐up
Haemophilia, Volume 32, Issue 6, Page 1513-1521, November/December 2026.
-
The XX Factor in Hemophilia: Diagnostic, Therapeutic, and Research Gaps for Women and Girls
Haemophilia, Volume 32, Issue 6, Page 1481-1487, November/December 2026.
-
Patient‐Reported Outcome Measures and Clinical Performance in Hemophilia: Implications for Person‐Centered Care
Haemophilia, Volume 32, Issue 6, Page 1455-1461, November/December 2026.
-
Prevalence of F8 Intron 22 Inversion in Severe Haemophilia A: Molecular Insights From a Cohort of Punjab Province of Pakistan
Haemophilia, Volume 32, Issue 6, Page 1498-1504, November/December 2026.
-
Quality of Life in People With Haemophilia: Results in the Framework of a Nationwide Registry in Colombia
Haemophilia, Volume 32, Issue 6, Page 1462-1470, November/December 2026.
-
Ten‐year Demographic and Clinical Characterisation of People With Haemophilia: The Colombian Registry Experience
Haemophilia, Volume 32, Issue 6, Page 1471-1480, November/December 2026.
-
Use of an Oral Health‐Related Quality of Life Instrument to Measure Unmet Dental Care Needs in Adults With Inherited Bleeding Disorders
Haemophilia, Volume 32, Issue 6, Page 1387-1396, November/December 2026.
-
Italian Patients Journey for Gene Therapy in Haemophilia A
Haemophilia, Volume 32, Issue 6, Page 1397-1412, November/December 2026.
-
Mortality and Relapse Patterns in Acquired Hemophilia A: A Single‐Centre Experience and Systematic Review With Proportional Meta‐Analysis
Haemophilia, Volume 32, Issue 6, Page 1556-1560, November/December 2026.
-
Predictors and Clinical Impact of Time to Diagnosis in Acquired Haemophilia A: An 11‐Year Retrospective Cohort Study
Haemophilia, Volume 32, Issue 6, Page 1540-1544, November/December 2026.
-
Clinical Outcomes of Efanesoctocog Alfa Prophylaxis in Children With Severe Haemophilia A: Interim Data From XTEND‐ed
Haemophilia, Volume 32, Issue 6, Page 1535-1539, November/December 2026.
-
Pathogenesis of Haemophilia A in a Chinese Family With F8‐Intron 22 Inversion and Skewed X‐Chromosome Inactivation
Haemophilia, Volume 32, Issue 6, Page 1545-1547, November/December 2026.
-
Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching Study
Haemophilia, Volume 32, Issue 6, Page 1548-1553, November/December 2026.
-
Response to Letter to the Editor: Pharmacokinetic Variability in Anti‐TFPI Therapies: Why Absolute Metrics Matter for Plasma Monitoring
Haemophilia, Volume 32, Issue 6, Page 1554-1555, November/December 2026.
-
Severe Bleeding Disorders Patients Who Developed Excess Weight Gain During the COVID‐19 Pandemic Revert to Their Pre‐Pandemic Weight and BMI Percentiles
Haemophilia, Volume 32, Issue 6, Page 1532-1534, November/December 2026.
-
Bridging the Gap: A Systematic Review of Modern Hemophilia Therapies and Global Inequities in Clinical Trial Participation
Haemophilia, Volume 32, Issue 6, Page 1320-1330, November/December 2026.